[1] LENG Z, ZHU R, HOU W, et al. Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia. Aging Dis. 2020;11(2):216-228.
[2] CHEN J, HU C, CHEN L, et al. Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment. Engineering (Beijing). 2020;6(10):1153-1161.
[3] GALIPEAU J, SENSÉBÉ L. Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. Cell Stem Cell. 2018;22(6):824-833.
[4] BARBASH IM, CHOURAQUI P, BARON J, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003; 108(7):863-868.
[5] JI SZ, XIAO SC, LUO PF, et al. An epidermal stem cells niche microenvironment created by engineered human amniotic membrane. Biomaterials. 2011;32(31):7801-7811.
[6] WANG X, JIANG B, SUN H, et al. Noninvasive application of mesenchymal stem cell spheres derived from hESC accelerates wound healing in a CXCL12-CXCR4 axis-dependent manner. Theranostics. 2019;9(21):6112-6128.
[7] JUNG HH, PARK K, HAN DK. Preparation of TGF-β1-conjugated biodegradable pluronic F127 hydrogel and its application with adipose-derived stem cells. J Control Release. 2010;147(1):84-91.
[8] SU J, DING L, CHENG J, et al. Transplantation of adipose-derived stem cells combined with collagen scaffolds restores ovarian function in a rat model of premature ovarian insufficiency. Hum Reprod. 2016;31(5): 1075-1086.
[9] LI L, DUAN X, FAN Z, et al. Mesenchymal Stem Cells in Combination with Hyaluronic Acid for Articular Cartilage Defects. Sci Rep. 2018;8(1):9900.
[10] MARMOTTI A, ROSSI R, CASTOLDI F, et al. PRP and articular cartilage: a clinical update. Biomed Res Int. 2015;2015:542502.
[11] ABRAMS GD, FRANK RM, FORTIER LA, et al. Platelet-rich plasma for articular cartilage repair. Sports Med Arthrosc Rev. 2013;21(4):213-219.
[12] PAVLOVIC V, CIRIC M, JOVANOVIC V, et al. Platelet Rich Plasma: a short overview of certain bioactive components. Open Med (Wars). 2016;11(1):242-247.
[13] HERSANT B, SID-AHMED M, BRAUD L, et al. Platelet-Rich Plasma Improves the Wound Healing Potential of Mesenchymal Stem Cells through Paracrine and Metabolism Alterations. Stem Cells Int. 2019; 2019:1234263.
[14] 刘超,张丽君,陶昊,等.基于细胞生物学方法比较5种不同组织来源间充质干细胞的特征[J].中国组织工程研究,2019,23(33): 5334-5340.
[15] LANGFELDER P, HORVATH S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.
[16] YU G, WANG LG, HAN Y, et al. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-287.
[17] OTASEK D, MORRIS JH, BOUÇAS J, et al. Cytoscape Automation: empowering workflow-based network analysis. Genome Biol. 2019; 20(1):185.
[18] SCHENONE M, FURIE BC, FURIE B. The blood coagulation cascade. Curr Opin Hematol. 2004;11(4):272-277.
[19] MANN KG, KRUDYSZ-AMBLO J, BUTENAS S. Tissue factor controversies. Thromb Res. 2012;129 Suppl 2(Suppl 2):S5-7.
[20] SUN L, LIU Y, LIN S, et al. Early growth response gene-1 and hypoxia-inducible factor-1α affect tumor metastasis via regulation of tissue factor. Acta Oncol. 2013;52(4):842-851.
[21] MOHYELDIN A, GARZÓN-MUVDI T, QUIÑONES-HINOJOSA A. Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell. 2010;7(2):150-161.
[22] WIESE DM, RUTTAN CC, WOOD CA, et al. Accumulating Transcriptome Drift Precedes Cell Aging in Human Umbilical Cord-Derived Mesenchymal Stromal Cells Serially Cultured to Replicative Senescence. Stem Cells Transl Med. 2019;8(9):945-958.
[23] BEVILACQUA MP, POBER JS, MAJEAU GR, et al. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984;160(2):618-623.
[24] FOLCO EJ, MAWSON TL, VROMMAN A, et al. Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1α and Cathepsin G. Arterioscler Thromb Vasc Biol. 2018;38(8):1901-1912.
[25] SASSA Y, HATA Y, MURATA T, et al. Functional role of Egr-1 mediating VEGF-induced tissue factor expression in the retinal capillary endothelium. Graefes Arch Clin Exp Ophthalmol. 2002;240(12):1003-1010.
[26] FRIEDMAN R, BETANCUR M, BOISSEL L, et al. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Biol Blood Marrow Transplant. 2007;13(12):1477-1486.
[27] 刘婷.脐带间充质干细胞体外扩增研究及其分泌细胞因子的高通量筛查[D].北京:中国人民解放军军事医学科学院, 2012.
[28] XU J, ZGHEIB C, HODGES MM, et al. Mesenchymal stem cells correct impaired diabetic wound healing by decreasing ECM proteolysis. Physiol Genomics. 2017;49(10):541-548.
[29] ALMALKI SG, AGRAWAL DK. Effects of matrix metalloproteinases on the fate of mesenchymal stem cells. Stem Cell Res Ther. 2016;7(1):129.
[30] TATSUMI K, OHASHI K, MATSUBARA Y, et al. Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism. Biochem Biophys Res Commun. 2013;431(2):203-209.
[31] ANTEBI B, RODRIGUEZ LA 2ND, WALKER KP 3RD, et al. Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells. Stem Cell Res Ther. 2018;9(1):265.
[32] REDONDO-CASTRO E, CUNNINGHAM CJ, MILLER J, et al. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming. Stem Cell Res Ther. 2018; 9(1):11.
[33] TOBITA M, TAJIMA S, MIZUNO H. Adipose tissue-derived mesenchymal stem cells and platelet-rich plasma: stem cell transplantation methods that enhance stemness. Stem Cell Res Ther. 2015;6:215.
[34] MISHRA A, TUMMALA P, KING A, et al. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods. 2009;15(3):431-435.
[35] MOLL G, ANKRUM JA, KAMHIEH-MILZ J, et al. Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines. Trends Mol Med. 2019;25(2):149-163.
|